Next Article in Journal
Association Between Polymorphisms of VDR, COL1A1, and LCT Genes and Bone Mineral Density in Belarusian Women With Severe Postmenopausal Osteoporosis
Previous Article in Journal
Influences of Genetic Variation of Endothelin-1 Gene on Effects of 16-Week Combined Exercise on Clinical and Physical Parameters in Middle-Aged Women
Article Menu
Issue 2 (May) cover image

Export Article

Open AccessReview
Medicina 2018, 54(2), 24;

Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment

Department of Cardiology, Medical Academy, Hospital of Lithuanian University of Health Sciences, Eivenių g. 2, 50161 Kaunas, Lithuania
Author to whom correspondence should be addressed.
Received: 21 February 2018 / Revised: 19 April 2018 / Accepted: 20 April 2018 / Published: 25 April 2018
Full-Text   |   PDF [492 KB, uploaded 3 May 2018]   |  


Degenerative aortic stenosis (DAS) is the most frequently diagnosed heart valve disease in Europe and North America. DAS is a chronic progressive disease which resembles development of atherosclerosis. Endothelial dysfunction, lipid infiltration, calcification and ossification are evidenced in both diseases. The same risk factors such as older age, male sex, smoking, and elevated levels of lipids are identified. The effect of smoking, visceral obesity, metabolic syndrome, hypercholesterolemia, low-density lipoprotein, high-density lipoprotein, lipoprotein(a), adiponectin and apolipoprotein(a) on development of DAS are being studied. The search for genetic ties between disorders of lipid metabolism and DAS has been started. DAS is characterized by a long symptom-free period which can last for several decades. Aortic valve replacement surgery is necessary when the symptoms occur. The lipid-lowering therapy effect on stopping or at least slowing down the progression of DAS was studied. However, the results of the conducted clinical trials are controversial. In addition, calcium homeostasis, bone metabolism and calcinosis-reducing medication are being studied. Although prospective randomized clinical trials have not demonstrated any positive effect of statins used for slowing progression of the disease, statins are still recommended for patients with dyslipidemia. Recent study has suggested that a specific modification of treatment, based on severity of disease, may have a beneficial effect in patients with aortic sclerosis and mild DAS. New clinical studies analyzing new treatment possibilities which could correct the natural course of the disease and reduce the need for aortic valve replacement by surgery or transcatheter treatment interventions are needed. View Full-Text
Keywords: degenerative aortic stenosis; lipoproteins; dyslipidemia; statins; medical treatment degenerative aortic stenosis; lipoproteins; dyslipidemia; statins; medical treatment

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Kleinauskienė, R.; Jonkaitienė, R. Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment. Medicina 2018, 54, 24.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Medicina EISSN 1010-660X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top